Cardiac inflammation involving in PKCε or ERK1/2-activated NF-κB signalling pathway in mice following exposure to titanium dioxide nanoparticles

Journal of Hazardous Materials

Volumn 313, Issue , 2016, Pages 68-77

  Yu, Xiaohong ^a   Hong, Fashui ^b   Zhang, Yu Qing ^a  

^a SOOCHOW UNIVERSITY   (China)

^b HUAIYIN NORMAL UNIVERSITY   (China)

Author keywords

Cardiac damage; Inflammatory response; Mice; Molecular mechanisms; Titanium dioxide nanoparticles

Indexed keywords

CALCIUM; CONSUMER PRODUCTS; IMMUNOLOGY; MAMMALS; NANOPARTICLES; OXIDES; PATHOLOGY; TITANIUM; TITANIUM DIOXIDE;

CARDIAC DAMAGE; INFLAMMATORY RESPONSE; MICE; MOLECULAR MECHANISM; TITANIUM DIOXIDE NANOPARTICLES;

HEART;

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA INTERFERON; BETA 1 ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAGNESIUM ION; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN INHIBITOR; PROTEIN KINASE C EPSILON; SODIUM ION; TITANIUM DIOXIDE NANOPARTICLE; TUMOR NECROSIS FACTOR ALPHA; NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

ANATOMY; CARDIOLOGY; CARDIOVASCULAR DISEASE; CELLS AND CELL COMPONENTS; CHEMICAL COMPOUND; DOSE-RESPONSE RELATIONSHIP; ENZYME ACTIVITY; HISTOPATHOLOGY; MOLECULAR ANALYSIS; NANOPARTICLE; PARTICULATE MATTER; POLLUTION EXPOSURE; RODENT; SWELLING; TOXICOLOGY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDITIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE CELL; HISTOPATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; HEART; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOPHYSIOLOGY;

MUS;

ANIMALS; FEMALE; HEART; INFLAMMATION; MICE; MICE, INBRED ICR; NANOPARTICLES; NF-KAPPA B; PROTEIN KINASE C-EPSILON; SIGNAL TRANSDUCTION; TITANIUM;

EID: 84961990869     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2016.03.088     Document Type: Article

References (102)

1. Pfaff G., Reynders P. Angle-dependent optical effects deriving from submicron structures of films and pigments. Chem. Rev. 1999, 99:1963-1982.
2. 2 porous films by anodization. Prog. Org. Coat. 1992, 20:105-138.
3. Skocaj M., Filipic M., Petkovic J., Novak S. Titanium dioxide in our everyday life; is it safe?. Radiol. Oncol. 2011, 45:227-247.
4. 2. Solid State Commun. 2006, 137:154-157.
5. Kaida T., Kobayashi K., Adachi M., Suzuki F. Optical characteristics of titanium oxide interference film and the film laminated with oxides and their applications for cosmetics. J. Cosmet. Sci. 2004, 55:219-220.
6. Weir A., Westerhoff P., Fabricius L., Hristovski K., von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012, 46:2242-2250.
7. 2. AIChE. J. 2005, 51:2298-2310.
8. 3 composite membranes for environmental applications. Appl. Catal. B: Environ. 2006, 63:60-67.
9. Linkov I., Satterstrom F.K., Corey L.M. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine 2008, 4:167-171.
10. Elsaesser A., Howard C.V. Toxicology of nanoparticles. Drug. Deliv. Rev. 2012, 64:129-137.
11. Brook R.D., Rajagopalan S., Pope C.A., Brook J.R., Bhatnagar A., DiezRoux A.V., Holguin F., Hong Y., Luepker R.V., Mittleman M.A., Peters A., Siscovick D., Smith S.C., Whitsel L., Kaufman J.D. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378.
12. Sun Q., Hong X., Wold L.E. Cardiovascular effects of ambient particulate air pollution exposure. Circulation 2010, 121:2755-2765.
13. Peters A., Dockery D.W., Muller J.E., Mittleman M.A. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001, 103:2810-2815.
14. Sullivan J., Sheppard L., Schreuder A., Ishikawa N., Siscovick D., Kaufman J. Relation between short-term fine-particulate matter exposure and onset of myocardial infarction. Epidemiology 2005, 16:41-48.
15. Allen R.W., Criqui M.H., Diez Roux A.V., Allison M., Shea S., Detrano R., Sheppard L., Wong N.D., Stukovsky K.H., Kaufman J.D. Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis. Epidemiology 2009, 20:254-264.
16. Araujo J.A., Nel A.E. Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress. Part. Fibre Toxicol. 2009, 6:24.
17. Puett R.C., Hart J.E., Yanosky J.D., Paciorek C., Schwartz J., Suh H., Speizer F.E., Laden F. Chronic fine and coarse particulate exposure mortality, and coronary heart disease in the nurses' health study. Environ. Health Perspect. 2009, 117:1702-1706.
18. Simkhovich B.Z., Kleinman M.T., Kloner R.A. Particulate air pollution and coronary heart disease. Curr. Opin. Cardiol. 2009, 24:604-609.
19. Sun Q.Q., Tan D.L., Zhou Q.P., Liu X.R., Cheng Z., Liu G., Zhu M., Sang X.Z., Gui S.X., Cheng J., Hu R.P., Tang M., Hong F.S. Oxidative damage of lung and its protective mechanism in mice caused by long term exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res A 2012, 100:2554-2562.
20. Sun Q.Q., Tan D.L., Ze Y.G., Sang X.Z., Liu X.R., Gui S.X., Cheng Z., Cheng J., Hu R.P., Gao G.D., Liu G., Zhu M., Zhao X.Y., Sheng L., Wang L., Tang M., Hong F.S. Pulmotoxicological effects caused by long-term titanium dioxide nanoparticles exposure in mice. J. Hazard. Mater. 2012, 235-236:47-53.
21. Hashiguchia S., Yoshidab H., Akashic T., Komemotoa K., Uedaa T., Ikarashid Y., Miyauchic A., Konnob K., Yamanakab S., Hirosee A., Kurokawab M., Watanabe W. Titanium dioxide nanoparticles exacerbate pneumonia in respiratory syncytial virus (RSV)-infected mice. Environ. Toxicol. Pharm. 2015, 8:79-86.
22. Halappanavar S., Jackson P., Williams A., Jensen K.A., Hougaard K.S., Vogel U., Yauk C.L., Wallin H. Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study. Environ. Mol. Mutagen. 2011, 52:425-439.
23. 2 and liver DNA from mice in vivo. Nanoscale Res. Lett. 2010, 5:108-115.
24. Cui Y.L., Gong X.L., Duan Y.M., Li N., Hu R.P., Liu H.T., Hong M.M., Zhou M., Wang L., Wang H., Hong F.S. Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium dioxide nanoparticles. J. Hazard. Mater. 2010, 183:874-880.
25. 2NP-induced hepatic inflammation. J. Agric. Food Chem. 2014, 62(28):6871-6878.
26. Alarifi S., Ali D., Al-Doaiss A.A., Ali B.A., Ahmed M., Al-Khedhairy A.A. Histologic and apoptotic changes induced by titanium dioxide nanoparticles in the livers of rats. Int. J. Nanomed. 2013, 8:3937-3943.
27. Azim S.A., Darwish H.A., Rizk M.Z., Ali S.A., Kadry M.O. Amelioration of titanium dioxide nanoparticles-induced liver injury in mice: possible role of some antioxidants. Exp. Toxicol. Pathol. 2015, 3:5-14.
28. 2. J. Exp. Nanosci. 2010, 5:447-462.
29. Bruno M.E., Tasat D.R., Ramos E., Paparella M.L., Evelson P., Rebagliati R.J., Cabrini R.L., Guglielmotti M.B., Olmedo D.G. Impact through time of different sized titanium dioxide particles on biochemical and histopathological parameters. J. Biomed. Mater. Res A. 2014, 102(5):1439-1448.
30. Huang K.T., Wu C.T., Huang K.H., Lin W.C., Chen C.M., Guan S.S., Chiang C.K., Liu S.H. Titanium nanoparticle inhalation induces renal fibrosis in mice via an oxidative stress upregulated transforming growth factor-β pathway. Chem. Res. Toxicol. 2015, 28(3):354-364.
31. 2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney. J. Agric. Food Chem. 2015, 63(5):1639-1647.
32. Li N., Duan Y., Hong M., Zheng L., Fei M., Zhao X., Wang J., Cui Y., Liu H., Cai J., Gong S., Wang H., Hong F. Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules. Toxicol. Lett. 2010, 195(2-3):161-168.
33. 2. Biol. Trace Elem. Res. 2011, 140(2):186-197.
34. Sang X., Zheng L., Sun Q., Li N., Cui Y., Hu R., Gao G., Cheng Z., Cheng J., Gui S., Liu H., Zhang Z., Hong F. The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. A 2012, 100(4):894-902.
35. Sang X., Fei M., Sheng L., Zhao X., Yu X., Hong J., Ze Y., Gui S., Sun Q., Ze X., Wang L., Hong F. Immunomodulatory effects in the spleen-injured mice following exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. 2014, 102A:3562-3572.
36. Sheng L., Wang L., Sang X., Zhao X., Hong J., Cheng S., Yu X., Liu D., Xu B., Hu R., Sun Q., Cheng J., Cheng Z., Gui S., Hong F. Nano-sized titanium dioxide-induced splenic toxicity: a biological pathway explored using microarray technology. J. Hazard. Mater. 2014, 278:180-188.
37. Sang X., Li B., Ze Y., Hong J., Ze X., Gui S., Sun Q., Liu H., Zhao X., Sheng L., Liu D., Yu X., Wang L., Hong F. Toxicological mechanisms of nanosized titanium dioxide-induced spleen injury in mice after repeated peroral application. J. Agric. Food. Chem. 2013, 61:5590-5599.
38. 2 delivered to the abdominal cavity. Biomaterials 2010, 31:99-105.
39. 2 nanoparticles. Biomaterials 2010, 31:8043-8050.
40. 2 nanoparticles induced hippocampal neuroinflammation in mice. PLoS One 2014, 9(3):e92230.
41. 2 nanoparticles. J. Hazard. Mater. 2014, 264:219-229.
42. 2-induced reproductive system dysfunction and its mechanism in female mice. PLoS One 2013, 8(4):e59378.
43. Gao G., Ze Y., Li B., Zhao X., Zhang T., Sheng L., Hu R., Gui S., Sang X., Sun Q., Cheng J., Cheng Z., Wang L., Tang M., Hong F. Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2012, 243:19-27.
44. Gao G., Ze Y., Zhao X., Sang X., Zheng L., Ze X., Gui S., Sheng L., Sun Q., Hong J., Yu X., Wang L., Hong F., Zhang X. Titanium dioxide nanoparticle-induced testicular damage spermatogenesis suppression, and gene expression alterations in male mice. J. Hazard. Mater. 2013, 258-259:133-143.
45. Zhao X., Sheng L., Wang L., Hong J., Yu X., Sang X., Sun Q., Ze Y., Hong F. Mechanisms of nanosized titanium dioxide-induced testicular oxidative stress and apoptosis in male mice. Part Fibre Toxicol. 2014, 11:47.
46. Sha B., Gao W., Wang S., Li W., Liang X., Xu F., Lu T.J. Nano-titanium dioxide induced cardiac injury in rat under oxidative stress. Food Chem. Toxicol. 2013, 58:280-288.
47. Husain M., Wu D., Saber A.T., Decan N., Jacobsen N.R., Williams A., Yauk C.L., Wallin H., Vogel U., Halappanavar S. Intratracheally instilled titanium dioxide nanoparticles translocate to heart and liver and activate complement cascade in the heart of C57BL/6 mice. Nanotoxicology 2015, 20:1-10.
48. Savi M., Rossi S., Bocchi L., Gennaccaro L., Cacciani F., Perotti A., Amidani D., Alinovi R., Goldoni M., Aliatis P.P., Lottici I., Bersani D., Campanini M., Pinelli S., Petyx M., Frati C., Gervasi A., Urbanek K., Quaini F., Buschini A., Stilli D., Rivetti C., Macchi E., Mutti A., Miragoli M., Zaniboni M. Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. Part Fibre Toxicol. 2014, 11(1):63.
49. Helfenstein M., Miragoli M., Rohr S., Müller L., Wick P., Mohr M., Gehr P., Rothen-Rutishauser B. Effects of combustion-derived ultrafine particles and manufactured nanoparticles on heart cells in vitro. Toxicology 2008, 253(1-3):70-78.
50. Sheng L., Wang X., Sang X., Ze Y., Zhao X., Liu D., Gui S., Sun Q., Cheng J., Cheng Z., Hu R., Wang L., Hong F. Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide. J. Biomed. Mater. Res. A 2013, 101(11):3238-3246.
51. 2 nanoparticle-induced atherosclerosis in mice. J. Hazard. Mater. 2014, 280:364-371.
52. 2 nanoparticle-induced myocarditis in mice. Nanoscale Res. Lett. 2015, 10:326.
53. 2 particles. Biol. Trace Elem. Res. 2009, 129:170-180.
54. 2 nanoparticles. J. Biomed. Mater. Res. A 2011, 96:221-229.
55. Han S.G., Newsome B., Hennig B. Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. Toxicology 2013, 306:1-8.
56. Garg R., Blando J., Perez C.J., Wang H., Benavides F.J., Kazanietz M.G. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKC epsilon). J. Biol. Chem. 2012, 287(44):37570-37582.
57. Li R.C., Ping P., Zhang J., Wead W.B., Cao X., Gao J., Zheng Y., Huang S., Han J., Bolli R. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2000, 279(4):H1679-H1689.
58. Dutra R.C., Bicca M.A., Segat G.C., Silva K.A., Motta E.M., Pianowski L.F., Costa R., Calixto J.B. The antinociceptive effects of the tetracyclic triterpene euphol in inflammatory and neuropathic pain models: the potential role of PKC. Neuroscience 2015, 10(303):126-137.
59. Tanaka T., Iino M. Nuclear translocation of p65 is controlled by sec6 via the degradation of IκBα. J. Cell. Physiol. 2015, 6.
60. Syed Hussein S.S., Alfarizal Kamarudin M.N., Kadir H.A. (+)-Catechin attenuates NF-(B activation through regulation of akt MAPK, and AMPK signaling pathways in LPS-induced BV-2 microglial cells. Am. J. Chin. Med. 2015, 30:1-26.
61. Cheon S.Y., Chung K.S., Jeon E., Nugroho A., Park H.J., An H.J. Anti-inflammatory activity of saxifragin via inhibition of NF-(B involves caspase-1 activation. J. Nat. Prod. 2015, 78(7):1579-1585.
62. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
63. Hu R.P., Zheng L., Zhang T., Cui Y.L., Gao G.D., Cheng Z., Cheng J., Tang M., Hong F.S. Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2011, 191:32-40.
64. National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington DC.
65. Gui S., Zhang Z., Zheng L., Cui Y., Liu X., Li N., Sang X., Sun Q., Gao G., Cheng Z., Cheng J., Wang L., Tang M., Hong F. Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2011, 15(195):365-370.
66. Baisch B.L., Corson N.M., Wade-Mercer P., Gelein R., Kennell A.J., Oberdörster G., Elder A. Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol. 2014, 11:5.
67. Scherbart A.M., Langer J., Bushmelev A., van Berlo D., Haberzettl P., van Schooten F.J., Schmidt A.M., Rose C.R., Schins R.P., Albrecht C. Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms. Part Fibre Toxicol. 2011, 13(8):31.
68. Shin J.A., Lee E.J., Seo S.M., Kim H.S., Kang J.L., Park E.M. Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse. Neuroscience 2010, 165(2):445-454.
69. Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., Saiki I. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2 TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 2003, 278:36916-36923.
70. Perez D.M., Papay R.S., Shi T. Alpha1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Mol. Pharmacol. 2009, 76(1):144-152.
71. Wang F., Qiao L., Chen L., Zhang C., Wang Y., Wang Y., Liu Y., Zhang N. The immunomodulatory activities of pullulan and its derivatives in human pDC-like CAL-1 cell line. Int. J. Biol. Macromol. 2016, 86:764-771.
72. Niessen A., Heyder P., Krienke S., Blank N., Tykocinski L.O., Lorenz H.M., Schiller M. Apoptotic-cell-derived membrane microparticles and IFN-α induce an inflammatory immune response. J. Cell. Sci. 2015, 128(14):2443-2453.
73. 2+ signaling and the proliferation of airway smooth muscle cells. Eur. J. Pharmacol. 2014, 740:733-741.
74. 2+ ATPase. Arch. Biochem. Biophys. 1988, 263(2):281-292.
75. Hall J.E. Guyton and Hall, Textbook of Medical Physiology 2011, Saunders/Elsevier.
76. + concentration. J. Physiol. 2014, 592(24):5355-5371.
77. +-ATPase in the heart. J. Physiol. 2015, 593(6):1361-1382.
78. +/Ca+-exchanger modulates intercellular communication. Circ. Res. 2007, 100:1026-1035.
79. 2+ exchanger in failing human myocardium. Circulation 1996, 94:992-1002.
80. Despa S., Islam M.A., Weber C.R., Pogwizd S.M., Bers D.M. Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 2002, 105(21):2543-2548.
81. Nam S.J., Han S.H., Kim H.W., Hyun C. The cardiac biomarker sodium-calcium exchanger (NCX-1) can differentiate between heart failure and renal failure: a comparative study of NCX-1 expression in dogs with chronic mitral valvular insufficiency and azotemia. J. Vet. Intern. Med. 2010, 24(6):1383-1387.
82. Liew C.C. Expressed genome molecular signatures of heart failure. Clin. Chem. Lab. Med. 2005, 43:462-469.
83. Seiler P.U., Stypmann J., Breithardt G., Schulze-Bahr E. Real-time RT-pCR for gene expression profiling in blood of heart failure patients-a pilot study: gene expression in blood of heart failure patients. Basic Res. Cardiol. 2004, 99:230-238.
84. + pump rate in rat and rabbit ventricular myocytes. J. Physiol. 2002, 539:133-143.
85. + transport in the normal and failing heart-remember the balance. J. Mol. Cell. Cardiol. 2013, 61:2-10.
86. Yaniv Y., Ganesan A., Yang D., Ziman B.D., Lyashkov A.E., Levchenko A., Zhang J., Lakatta E.G. Real-time relationship between PKA biochemical signal network dynamics and increased action potential firing rate in heart pacemaker cells: yaniv. Kinetics of PKA activation in heart pacemaker cells. J. Mol. Cell. Cardiol. 2015, 86:168-178.
87. 2+ handling and cardiomyopathy. J. Mol. Cell. Cardiol. 2015, 87:38-47.
88. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc. Res. 2007, 73:631-640.
89. Zhang M., Hagenmueller M., Riffel J.H., Kreusser M.M., Bernhold E., Fan J., Katus H.A., Backs J., Hardt S.E. Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy. Hypertension 2015, 65(2):335-344.
90. 2+/calmodulin-dependent protein kinase II- dependent activation of contractility in ferret aorta. J. Physiol. 2000, 526:367-374.
91. Rokolya A., Singer H.A. Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle. Am. J. Physiol. Cell Physiol. 2000, 278(C):537-545.
92. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ. Res. 1997, 81:575-584.
93. Mangmool S., Shukla A.K., Rockman H.A. Beta-arrestin-dependent activation of Ca(2 + )/calmodulin kinase II after beta(1)-adrenergic receptor stimulation. J. Cell. Biol. 2010, 189:573-587.
94. Cotecchia S. The α1-adrenergic receptors: diversity of signaling networks and regulation. J. Recept. Signal. Transduct. Res. 2010, 30(6):410-419.
95. Dorn G.W., Brown J.H. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc. Med. 1999, 9(1-2):26-34.
96. Graham R.M., Perez D.M., Hwa J., Piascik M.T. Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ. Res. 1996, 78(5):737-749.
97. Clerk A., Sugden P.H. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ. Res. 2000, 86(10):1019-1023.
98. Thorburn A., Thorburn J., Chen S.Y., Powers S., Shubeita H.E., Feramisco J.R., Chien K.R. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J. Biol. Chem. 1993, 268(3):2244-2249.
99. Chiloeches A., Paterson H.F., Marais R., Clerk A., Marshall C.J., Sugden P.H. Regulation of Ras·GTP loading and ras-raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol ester. J. Biol. Chem. 1999, 274:19762-19770.
100. Koide Y., Tamura K., Suzuki A., Kitamura K., Yokoyama K., Hashimoto T., Hirawa N., Kihara M., Ohno S., Umemura S. Differential induction of protein kinase C isoforms at the cardiac hypertrophy stage and congestive heart failure stage in Dahl salt-sensitive rats. Hypertens. Res. 2003, 26:421-426.
101. 2+-sensitive isoforms in the failing human heart. Circulation 1999, 99:384-391.
102. Dumont O., Mylroie H., Bauer A., Calay D., Sperone A., Thornton C., Hamdulay S.S., Ali N., Boyle J.J., Choo J.R., Samarel A.M., Haskard D.O., Randi A.M., Evans P.C., Mason J.C. Protein kinase C(activity induces anti-inflammatory and anti-apoptotic genes via an ERK1/2- and NF-(B-dependent pathway to enhance vascular protection. Biochem. J. 2012, 447(2):193-204.